73 results
Search Results
2. Effective clearance of Ara-U the major metabolite of cytosine arabinoside (Ara-C) by hemodialysis in a patient with lymphoma and end-stage renal failure
3. Vorbereitung zur Nierenersatztherapie
4. Meropenem pharmacokinetics in children and adolescents receiving hemodialysis
5. Pharmacokinetics of paclitaxel in an anephric patient
6. Pharmacokinetics of piperacillin and tazobactam in critically ill patients with renal failure, treated with continuous veno-venous hemofiltration (CVVH)
7. Pharmacokinetics and pharmacodynamics of lisinopril in advanced renal failure: Consequence of dose adjustment
8. Influence of renal function on the pharmacokinetics of diacerein after a single oral dose
9. Pharmacokinetics of lansoprazole in patients with renal or liver disease of varying severity
10. Pharmacokinetics and pharmacodynamics of quinaprilat after low dose quinapril in patients with terminal renal failure
11. Pharmacokinetics and tolerance of Gd-DOTA (DOTAREM) in healthy volunteers and in patients with chronic renal failure
12. Rebound of plasma vancomycin levels after haemodialysis with highly permeable membranes
13. Stereoselective pharmacokinetics of oral nitrendipine in elderly hypertensive patients with normal and impaired renal function
14. Clinical pharmacokinetics of the nifedipine/co-dergocrine combination in impaired liver and renal function
15. Multiple dose kinetics of ofloxacin and ofloxacin metabolites in haemodialysis patients
16. Relationship between renal function and disposition of oral cefixime
17. Pharmacokinetics of intravenous and oral chlordesmethyldiazepam in patients on regular haemodialysis
18. Pharmacodynamic and kinetic considerations on diuretics as a basis for differential therapy
19. Pharmacokinetics of SUN 1165, a new antiarrhythmic agent, in renal dysfunction
20. Comparative enantioselective pharmacokinetic studies of celiprolol in healthy volunteers and patients with impaired renal function
21. Elimination of amrinone during continuous veno-venous haemofiltration after cardiac surgery
22. The pharmacokinetics of nifurtimox in chronic renal failure
23. Effect of haemodialysis on the pharmacokinetics of cetirizine
24. Elimination of cefmenoxime during continuous haemofiltration
25. Delayed elimination of triamterene and its active metabolite in chronic renal failure
26. Pharmacokinetics of verapamil in patients with renal failure
27. Pharmacokinetic studies of cefoxitin in continuous ambulatory peritoneal dialysis
28. Pharmacokinetics of isosorbide dinitrate, isosorbide-2-nitrate and isosorbide-5-nitrate in renal insufficiency after repeated oral dosage
29. Effect of impairment of renal function on the accumulation and disposition of isoxicam
30. Pharmacokinetics of cimetidine and its sulphoxide metabolite during haemodialysis
31. The pharmacokinetics of theophylline and enprofylline in patients with liver cirrhosis and in patients with chronic renal disease
32. Pharmacokinetics of amiloride in renal and hepatic disease
33. Pharmacokinetics of TZU-0460, a new H2-receptor antagonist, in patients with impaired renal function
34. Disposition of azapropazone in chronic renal and hepatic failure
35. Pharmacokinetics of lisinopril in hypertensive patients with normal and impaired renal function
36. Pharmacokinetics of tocainide in patients with renal dysfunction and during haemodialysis
37. Antisecretory effect and oral pharmacokinetics of omeprazole in patients with chronic renal failure
38. Clinical pharmacokinetics and pharmacodynamics of fazadinium in renal failure
39. Paracetamol disposition and metabolite kinetics in patients with chronic renal failure
40. Kinetics of a high dose of piretanide in renal failure
41. Pharmacokinetics of hydrochlorothiazide in relation to renal function
42. Kinetics of morphine in patients with renal failure
43. Clofibrate disposition in renal failure and acute and chronic liver disease
44. Pharmacokinetics of tocainide in patients with severe renal failure
45. Pharmacokinetics of nitrendipine in terminal renal failure
46. Pharmacokinetics of cephacetrile in patients undergoing haemodialysis
47. Pharmacokinetic and pharmacodynamic modelling of atenolol in rabbits maintained on continuous peritoneal dialysis
48. Pharmacokinetics of mepindolol in patients with chronic renal failure
49. Kinetics of furosemide in children with chronic renal failure undergoing regular haemodialysis
50. Pharmacokinetics of acebutolol in patients with all grades of renal failure
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.